Meeting
2021 ASCO Annual Meeting
Molecular determinants of response to immune-oncology therapy in uterine carcinosarcoma.
Authors
Annelise M. Wilhite
University of South Alabama, Mobile, AL
Annelise M. Wilhite , Sharon Wu , Joanne Xiu , Britt Kristina Erickson , Rodney Paul Rocconi , Jubilee Brown , Thomas J. Herzog , Robert W. Holloway , John Wallbillich , Ira Seth Winer , Matthew A. Powell , Wolfgang Michael Korn , Nathaniel L. Jones
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Uterine Cancer
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 5582)
DOI
10.1200/JCO.2021.39.15_suppl.5582
Abstract #
5582
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Exploring molecular profiles and survival in hormone receptor-positive uterine serous carcinoma.
First Author: Amaranta Craig
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer.
First Author: Ryan H. Moy
Poster
2022 ASCO Annual Meeting
Microsatellite-stable tumors with high tumor mutational burden in association with tumor response to immune checkpoint inhibitor therapy across solid tumors and correlation with specific oncogenic alterations.
First Author: Imran Nizamuddin
Poster
2022 ASCO Annual Meeting
Impact of RAS mutations on immunologic characteristics of the tumor microenvironment (TME) in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC).
First Author: Mohamed E. Salem